Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -54.10x is 88% above its 5-year average of -437.09x, near the high end of its 5-year range (-2584.00x–-1.05x).
501.41% below its 12-month average of -9.00x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2027 (2026-06-30): -9.30x.
INTEREST COVERAGE RATIO
-54.10x
INTEREST COVERAGE RATIO AVG TTM
-9.00x
INTEREST COVERAGE RATIO AVG 3Y
-9.00x
INTEREST COVERAGE RATIO AVG 5Y
-437.09x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-501.41%
CURRENT VS 3Y AVG
-501.41%
CURRENT VS 5Y AVG
+87.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-740.06%
vs the sector median at left
Valion Bio, Inc.
Market Cap
$9.86M
Interest Coverage Ratio
-54.10x
TTM Avg
-9.00x
3Y Avg
-9.00x
5Y Avg
-437.09x
Market Cap
$9.83M
Interest Coverage Ratio
-12.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Interest Coverage Ratio
-129.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Valion Bio, Inc. (VBIO) | $9.86M | -54.10x | -9.00x | -9.00x | -437.09x |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -12.65x | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -129.91x | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | N/A | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.50M | -19.65x | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -57.26x | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A | N/A | N/A | N/A |
Interest Coverage
-54.1x
Debt/Equity
1.46
Current Ratio
1.11
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -9.30x |
| 2026-03-31 | -8.69x |
| 2022-09-30 | -2584.00x |
| 2021-12-31 | -14.79x |
| 2021-09-30 | -1.05x |
| 2021-06-30 | -4.73x |
| 2021-03-31 | -3.86x |
| 2020-12-31 | -2.80x |
| 2020-09-30 | -6.73x |
| 2020-06-30 | -38.60x |
